![Phillip A. Sharp](https://webapi.project-syndicate.org/library/fbdc80e233c6dd49e4eceea0b44ae265.square.1.jpg)
Phillip A. Sharp
Phillip A. Sharp, Institute Professor of Biology at MIT, is Director of Alnylam Pharmaceuticals Scientific Advisory Board and a recipient of the Nobel Prize in Physiology or Medicine.
-
What Biotech Innovation Needs
What Biotech Innovation Needs
Jun 2, 2022 Phillip A. Sharp & Julien Patris describe the confluence of factors needed to develop a vibrant life-sciences sector.